TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Technology
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE
6.1. Overview
6.2. Assays & Kits
6.3. Instruments & Analyzers
6.4. Software & Services
7. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY
7.1. Overview
7.2. RT-PCR
7.3. INAAT
7.4. Others
8. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION
8.1. Overview
8.2. Cancer
8.3. Infectious Diseases
8.4. Hematology
8.5. Endocrinology
8.6. Others
9. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER
9.1. Overview
9.2. Hospitals & Clinics
9.3. Diagnostic Centers
9.4. Others
10. GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY REGION
10.1. Overview
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. France
10.2.3. UK
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Australia
10.3.6. Rest of Asia-Pacific
10.4. Rest of the World
10.4.1. Middle East
10.4.2. Africa
10.4.3. Latin America
11. COMPANY LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Point-of-Care Molecular Diagnostics Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Global Point-of-Care Molecular Diagnostics Market
11.7. Key developments and Growth Strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales & Operating Income, 2022
11.8.2. Major Players R&D Expenditure. 2022
12. COMPANY PROFILES
12.1. Abbott Laboratories, Inc.
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Products Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. F. Hoffmann-La Roche Ltd
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Products Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. QIAGEN N.V.
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Products Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Becton, Dickinson and Company 
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Products Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Cepheid
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Products Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. Altona Diagnostics GmbH
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Products Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. Siemens Healthineers AG
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Products Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. Thermo Fisher Scientific, Inc.
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Products Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. ELITechGroup
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Products Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Trinity Biotech plc
12.10.1. Company Overview
12.10.2. Financial Overview
12.10.3. Products Offered
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SYNOPSIS, 2019–2030
TABLE 2 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET ESTIMATES & FORECAST, 2019–2030 (USD MILLION)
TABLE 3 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 4 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 5 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 6 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 7 NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 8 NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 9 NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 10 NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 11 US: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 12 US: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 13 US: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 14 US: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 15 CANADA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 16 CANADA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 17 CANADA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 18 CANADA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 1 EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 2 EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 3 EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 4 EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 5 GERMANY: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 6 GERMANY: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 7 GERMANY: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 8 GERMANY: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 9 FRANCE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 10 FRANCE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 11 FRANCE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 12 FRANCE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 13 ITALY: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 14 ITALY: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 15 ITALY: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 16 ITALY: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 17 SPAIN: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 18 SPAIN: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 19 SPAIN: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 20 SPAIN: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 21 UK: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 22 UK: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 23 UK: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 24 UK: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 25 REST OF EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 26 REST OF EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 27 REST OF EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 28 REST OF EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 29 ASIA-PACIFIC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 30 ASIA-PACIFIC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 31 ASIA-PACIFIC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 32 ASIA-PACIFIC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 33 JAPAN: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 34 JAPAN: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 35 JAPAN: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 36 JAPAN: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 37 CHINA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 38 CHINA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 39 CHINA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 40 CHINA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 41 INDIA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 42 INDIA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 43 INDIA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 44 INDIA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 45 AUSTRALIA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 46 AUSTRALIA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 47 AUSTRALIA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 48 AUSTRALIA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 49 SOUTH KOREA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 50 SOUTH KOREA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 51 SOUTH KOREA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 52 SOUTH KOREA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 53 REST OF ASIA-PACIFIC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 54 REST OF ASIA-PACIFIC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 55 REST OF ASIA-PACIFIC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 56 REST OF ASIA-PACIFIC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 57 REST OF THE WORLD: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 58 REST OF THE WORLD: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 59 REST OF THE WORLD: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 60 REST OF THE WORLD: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 61 MIDDLE EAST: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 62 MIDDLE EAST: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 63 MIDDLE EAST: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 64 MIDDLE EAST: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 65 AFRICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 66 AFRICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 67 AFRICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 68 AFRICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
TABLE 69 LATIN AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICE, 2019–2030 (USD MILLION)
TABLE 70 LATIN AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2019–2030 (USD MILLION)
TABLE 71 LATIN AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION, 2019–2030 (USD MILLION)
TABLE 72 LATIN AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2019–2030 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET
FIGURE 4 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE (%), BY PRODUCT & SERVICE, 2022
FIGURE 5 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE (%), BY TECHNOLOGY, 2022
FIGURE 6 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE (%), BY APPLICATION, 2022
FIGURE 7 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE (%), BY END USER, 2022
FIGURE 8 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE (%), BY REGION, 2022
FIGURE 9 NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE (%), BY REGION, 2022
FIGURE 10 EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE (%), BY REGION, 2022
FIGURE 11 ASIA-PACIFIC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE (%), BY REGION, 2022
FIGURE 12 REST OF THE WORLD: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SHARE (%), BY REGION, 2022
FIGURE 13 GLOBAL POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET: COMPANY SHARE ANALYSIS (%), 2022
FIGURE 14 ABBOTT LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 15 ABBOTT LABORATORIES, INC.: SWOT ANALYSIS
FIGURE 16 F. HOFFMANN-LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 17 F. HOFFMANN-LA ROCHE LTD: SWOT ANALYSIS
FIGURE 18 QIAGEN N.V.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 19 QIAGEN N.V.: SWOT ANALYSIS
FIGURE 20 BECTON, DICKINSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS
FIGURE 22 CEPHEID: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 23 CEPHEID: SWOT ANALYSIS
FIGURE 24 ALTONA DIAGNOSTICS GMBH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 25 ALTONA DIAGNOSTICS GMBH: SWOT ANALYSIS
FIGURE 26 SIEMENS HEALTHINEERS AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 27 SIEMENS HEALTHINEERS AG: SWOT ANALYSIS
FIGURE 28 THERMO FISHER SCIENTIFIC, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 THERMO FISHER SCIENTIFIC, INC.: SWOT ANALYSIS
FIGURE 30 ELITECHGROUP: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 ELITECHGROUP: SWOT ANALYSIS
FIGURE 32 TRINITY BIOTECH PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 TRINITY BIOTECH PLC: SWOT ANALYSIS
